OSLO, Norway, April 6, 2022 /PRNewswire/ — Notice is on condition that the Annual General Meeting of Nordic Nanovector ASA might be held on 28 April 2022, at 14:00 hours CEST at Advokatfirmaet Selmer, Tjuvholmen Allé 1, 0252 Oslo. The full discover with appendices and the advice from the Nomination (*28*) are connected. The discover and the paperwork to which it refers are additionally accessible on www.nordicnanovector.com.
Shareholders wishing to attend the Annual General Meeting, in individual or by proxy, should full and return the attendance kind or energy of legal professional kind connected to the discover to Nordea Bank Abp, Issuer Service, Postboks 1166 Sentrum, N-0107 Oslo, or by e-mail to [email protected] no later than 26 April 2022, 16:00 CEST. Attendance or proxies can also be registered electronically via Euronext Securities Oslo (previously VPS) Investor Services.
For additional info, please contact:
IR enquiries
Malene Brondberg, CFO
Cell: +44 7561 431 762
Email: [email protected]
Media Enquiries
Mark Swallow/Frazer Hall/David Dible (Citigate Dewe Rogerson)
Tel: +44 203 926 8535
Email: [email protected]
About Nordic Nanovector:
Nordic Nanovector is dedicated to develop and ship modern therapies to sufferers to deal with main unmet medical wants and advance most cancers care. The Company aspires to change into a pacesetter within the growth of focused therapies for haematological cancers. Nordic Nanovector’s lead scientific-stage candidate is Betalutin®, a novel CD37-concentrating on antibody-radionuclide-conjugate designed to advance the therapy of non-Hodgkin’s lymphoma (NHL). NHL is a sign with substantial unmet medical want, representing a rising market forecast to be value almost USD 29 billion by 2026. Nordic Nanovector retains world advertising and marketing rights to Betalutin® and intends to actively take part within the commercialisation of Betalutin® within the US and different main markets.
Further info might be discovered at www.nordicnanovector.com.
This info is topic to an obligation of disclosure pursuant to Section 5-12 of the Securities Trading Act.
This info was delivered to you by Cision http://news.cision.com
The following recordsdata can be found for obtain:
View unique content material:https://www.prnewswire.com/news-releases/nordic-nanovector-asa–notice-of-annual-general-meeting-on-28-april-2022-301518776.html
SOURCE Nordic Nanovector
Company Codes: Bloomberg:NANOV@NO, ISIN:NO0010597883, Oslo:NANOV, RICS:NANOV.OL
https://www.biospace.com/article/releases/nordic-nanovector-asa-discover-of-annual-normal-assembly-on-28-april-2022/
